Literature DB >> 11238532

Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.

O Hessman1, B Skogseid, G Westin, G Akerström.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome with multiple tumors of the endocrine pancreas, the parathyroid, the pituitary, and other tissues. The MEN1 gene at 11q13 is homozygously mutated in the majority of MEN1 tumors. Here we present a genome-wide loss of heterozygosity (LOH) screening of 23 pancreatic lesions, one duodenal tumor, and one thymic carcinoid from 13 MEN1 patients. Multiple allelic deletions were found. Fractional allelic loss varied from 6-75%, mean 31%. All pancreatic tumors displayed LOH on chromosome 11, whereas the frequency of losses for chromosomes 3, 6, 8, 10, 18, and 21 was over 30%. Different lesions from individual patients had discrepant patterns of LOH. Intratumoral heterogeneity was revealed, with chromosome 6 and 11 deletions in most tumor cells, whereas other chromosomal loci were deleted in portions of the analyzed tumor. Chromosome 6 deletions were mainly found in lesions from patients with malignant features. Fractional allelic loss did not correlate to malignancy or to tumor size. Our findings indicate that MEN1 pancreatic tumors fail to maintain DNA integrity and demonstrate signs of chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238532     DOI: 10.1210/jcem.86.3.7332

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

2.  MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair.

Authors:  Lorri R Marek; Molly C Kottemann; Peter M Glazer; Allen E Bale
Journal:  DNA Repair (Amst)       Date:  2008-02-06

3.  Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.

Authors:  Yue Zhao; Yimin Wang; Fudi Zhu; Jiayu Zhang; Xiao Ma; Dongwei Zhang
Journal:  Clin Exp Med       Date:  2020-01-24       Impact factor: 3.984

4.  Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred.

Authors:  Xiaohua Li; Jing Su; Li Zhao; Jingcheng Wu; Xiaoying Ding; Fang Fang; Yijie Wu; Haiyan Sun; Yongde Peng
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

5.  ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).

Authors:  Svetozar S Damjanovic; Jadranka A Antic; Valentina I Elezovic-Kovacevic; Dusko M Dundjerovic; Ivana T Milicevic; Bojana B Beleslin-Cokic; Bojana B Ilic; Gordana S Rodic; Annabel Berthon; Andrea Gutierrez Maria; Fabio R Faucz; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

6.  Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.

Authors:  Chanjuan Shi; Raul S Gonzalez; Zhiguo Zhao; Tatsuki Koyama; Toby C Cornish; Kenneth R Hande; Ronald Walker; Martin Sandler; Jordan Berlin; Eric H Liu
Journal:  Am J Clin Pathol       Date:  2015-03       Impact factor: 2.493

Review 7.  Menin and bone metabolism.

Authors:  Hiroshi Kaji
Journal:  J Bone Miner Metab       Date:  2012-04-28       Impact factor: 2.626

8.  Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.

Authors:  M Anlauf; A Perren; T Henopp; T Rudolf; N Garbrecht; A Schmitt; A Raffel; O Gimm; E Weihe; W T Knoefel; H Dralle; Ph U Heitz; P Komminoth; G Klöppel
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

9.  Direct binding of DNA by tumor suppressor menin.

Authors:  Ping La; Albert C Silva; Zhaoyuan Hou; Haoren Wang; Robert W Schnepp; Nieng Yan; Yigong Shi; Xianxin Hua
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

10.  MEN1 is a melanoma tumor suppressor that preserves genomic integrity by stimulating transcription of genes that promote homologous recombination-directed DNA repair.

Authors:  Minggang Fang; Fen Xia; Meera Mahalingam; Ching-Man Virbasius; Narendra Wajapeyee; Michael R Green
Journal:  Mol Cell Biol       Date:  2013-05-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.